Back to dataset

Inflammatory bowel disease national clinical audit of biological therapies (2015) Paediatric biological therapies data - IBD audit 2015

You're previewing the first 4 rows of this file.

Download this file
Health board / Trust name Sitename Participation status Crohn’s disease patients – time from diagnosis to initial treatment, years, Median (IQR) Initial treatment PCDAI score, Median (IQR) Crohn’s disease patients – remission achieved Crohn’s disease patients – on concomitant immunosuppression at start of treatment Crohn’s disease patients with adverse event recorded at 3 month follow-up Crohn’s disease patients –PROMs completed at start of treatment
Alder Hey Children’s NHS Foundation Trust Alder Hey Children’s Hospital Participant n=61, 1 (1, 3) n=52, 25 (12, 32) 23/32 (72%) 59/61 (97%) 1/34 (3%) 43/61 (71%)
Barts Health NHS Trust Barts and The London Children’s Hospital* Participant n=32, 2 (1, 3) n=0 n=0 18/21 (86%) (n<6 10/32 (31%)
Birmingham Children’s Hospital NHS Foundation Trust Birmingham Children’s Hospital Participant n=64, 1 (0, 2) n=17, 15 (5, 32) n<6 51/65 (79%) 4/49 (8%) 0/65 (0%)
Brighton and Sussex University Hospitals NHS Trust The Royal Alexandra Children’s Hospital* Participant n=6, 4 (2, 7) n=6, 26 (11, 35) n<6 (n=0 (n<6 5/6 (83%)